Year 7, Number 27, January 2005

 

Oncology

 

 


Dragosavac S.; Ramos CD.; Santos AO; Li LFRS; Lemos-Martini SHV; Etchebehere ECSC; Lima MCL; Camargo EE.

Division of Nuclear Medicine of the Department of Radiology and Department of Pediatrics, Faculty of Medical Sciences of Campinas State University (UNICAMP), Campinas, Brazil

Cita/Reference:
Dragosavac S.; Ramos CD.; Santos AO. et al. 99mTc -Sestamibi in differential diagnosis of congenital hypothyroidism in children under hormone therapy. Alasbimn Journal 7(27): January 2005



99mTc -Sestamibi in differential diagnosis of congenital hypothyroidism in children under hormone therapy


INTRODUCTION: Diagnosis of congenital hypothyroidism is made during neonatal trials and thyroid hormone reposition is essential during the first days after birth in affected patients. Differential diagnosis between the three possible etiologies - agenesis, ectopy and disgenesis - is important due to malignant transformation and familial prevalence of disgenesis. Thyroid scintigraphy with 99mTc-pertechnetate or 123/131I-iodine have been used for the differential diagnosis. The patients need to interrupt the hormone therapy for one month and follow the low iodine diet for fifteen days before the study. The lack of thyroid hormone has deleterious effects upon the brain in development and the damage is estimated as loss of 3 IQ points a month without hormone before age of 4. 99mTc-sestamibi could be an alternative for the differential diagnosis of congenital hypothyroidism before the age of four, once its uptake does not depend on thyroid hormone levels.

OBJECTIVE: Evaluation of 99mTc-sestamibi thyroid scintigraphy in the differential diagnosis of congenital hypothyroidism in children, without the interruption of the hormone treatment and without the low iodine diet.

METHODS: Eight patients were included in the study, with ages between 2 and 14 (medium 4.8 years old), 4 with the diagnosis of thyroid disgenesis, 2 with agenesis and 2 with sublingual thyroid. None of the patients interrupted the hormone treatment nor was placed on the low iodine diet before the study. The images of the anterior cervical region were obtained at 5 and 20 minutes after the intravenous injection of 110 to 260 MBq (3 to 7 mCi) of 99mTc-sestamibi, using a scintillation camera equipped with LEHR collimator. The images of the seringe with the radiotracer before and after the injection were also obtained for the calculation of the uptake.

RESULTS: All four patients with the diagnosis of disgenesis showed normal or increased uptake of 99mTc-sestamibi at 5 and 20 minutes (medium uptake 0.17% at 5 minutes and 0.13% at 20 minutes). No cervical or sublingual uptake of 99mTc-sestamibi was identified in 4 patients with diagnosis of agenesis or thyroid ectopy.

CONCLUSION: Thyroid scintigraphy with 99mTc-sestamibi was efficient in the differential diagnosis of congenital hypothyroidism, identifying patients with disgenesis, without the interruption of the hormone treatment.

 


Correlation Between PSA Level, Gleason Score and Bone Scan in Staging of Prostate Cancer Patients | Lymphatic Mapping and Sentinel Node Detection using 99mTc-Phytate in Cervix Cancer - 55 cases | Use of 99mTc-Phytate for Lymphoscintigraphy and Sentinel Node Biopsy in 858 Patients with Breast Cancer | Whole-Body Tc-99m Sestamibi Scintigraphy in the Pre-Operative Evaluation of differentiated Thyroid Carcinoma | Lymphatic Mapping and Detection of Sentinel Lymph Node in Vulvar Cancer | Calculation of a 99mTc sestamibi concentration index in suspect breast lesions. Where should the area of interest necessary to establish a reference value be? | Scintimammography with 99mTc sestamibi of suspect nodules - Quantitative analysis | Efficiency of scintimammography with 99mTc sestamibi in the detection of cancer | Identification of Sentinel Node in Breast Cancer: Injection of the radiopharmaceutical in four points | The influence of histological grading in the detection of breast carcinoma on scintimammography | Determinant factors of thyroid function outcome in patients with graves' Disease after radioiodine therapy | Parathyroid Scintigraphy with 99mTc-Sestamibi: The Value of Sequential Images to Plan Minimally Invasive Radioguided Parathyroidectomy | 99mTc -Sestamibi in differential diagnosis of congenital hypothyroidism in children under hormone therapy | Print

 

 

Sitio desarrollado por SISIB - Universidad de Chile